Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Bevacizumab-Refractory Metastatic RCC
NCT00089648Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Dec 2004; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00089648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089648.